Advanced technology. Exacting standards.

Implant Sciences Corporation (IMSC:OTCPK) develops and commercializes explosives trace detection (ETD) solutions for transportation and aviation security, force protection and law enforcement, critical infrastructure protection, and public safety markets.

Founded in 1984, Implant Sciences has a rich history of developing leading technologies in several markets. The company today is a pure play in global Security, Safety, and Defense (SS&D) markets. The Company's patented technology, used in its flagship product, the Quantum Sniffer™ QS-H150 handheld explosives trace detector, is in use throughout the world.

IMSC successfully introduced its first handheld explosive trace detection product in 2003 and has sold more than 1,500 ETD systems in over 30 countries. Homeland Security Research Corporation projects that the global ETD market will be approximately $1 billion by 2015.

The QS-H150 has been Designated a Qualified Anti-Terrorism Technology by the U.S. Department of Homeland Security pursuant to 6 U.S.C. § 441-444 (the Support Anti-terrorism by Fostering Effective Technologies Act of 2002, or "SAFETY Act") and 6 C.F.R. Part 25 (Regulations to Support Anti-terrorism by Fostering Effective Technologies).

The QS-B220 has been granted “Development Testing & Evaluation Designation” as a Qualified Anti-Terrorism Technology by the U.S. Department of Homeland Security pursuant to 6 U.S.C. § 441-444 (the Support Anti-terrorism by Fostering Effective Technologies Act of 2002, or “SAFETY Act”) and 6 C.F.R. § 25.4(f) (2006) (Regulations implementing the SAFETY Act).